TELL received the Top Innovator Award!
TELL received the Top Innovator Award from the World Economic Forum, in the UpLink and Manulife’s Prospering in Longevity Challenge! Learn more about the challenge and discover our profile on UpLink here.
TELL is building the leading voice biomarkers for Latin America
You can tell a lot about a person from the way they speak. For centuries doctors have been trained to listen closely to their patients’ voices for signs of illness, as subtle changes like slurring and tremors can be a sign that something is going on beneath the surface. To read the full article, please […]
Introducing TELL at TCIM 2024
Our CSO, Adolfo García, will be introducing TELL’s digital speech biomarker framework at the Tau Consortium Investigators’ Meeting 2024.
Research and entrepreneurship in neurosciences: diagnosis through speech (in Spanish)
Our CSO, Adolfo Garcia, unraveled TELL’s journey in an interview on how diseases are being detected through speech, the learnings of entrepreneurship and the paradox of progressing with speed and quality, for Wúru’s Walk the Talk podcast. You can watch the full interview here. Nuestro CSO, Adolfo García, desandó el camino de TELL en […]
TELL collaborates with Harvard Medical School for pioneering speech studies in patients with intracranial implants
After establishing a relationship with Harvard Medical School, TELL was selected to perform studies on speech changes in patients with intracranial electrodes suffering from epilepsy and Parkinson’s disease. Adolfo García, CSO and co-founder of TELL, comments that «we have a long-standing connection with Harvard, and a month ago we signed an agreement to evaluate how […]
Our CSO gets interviewed by Logan Plaster (Startup Health)
Casual conversation between Adolfo García (TELL’s CSO) and Logan Plaster (Startup Health’s Editor-in-chief) in the streets of Philadelphia. You can watch the interview here.
TELL is building the leading voice biomarkers for Latin America
Fernando Johann, PhD, and his team are bringing groundbreaking voice analysis research to patients through their AI-driven platform. With a strong focus on native Spanish and non-English speakers, TELL is focusing on making early Alzheimer’s detection more accessible. You can read the full article here.
Include Network meeting chaired by our CSO
Include Intermission at Alzheimer’s Association International Conference 2024 chaired by our CSO, Dr. Adolfo M. García.
Publication of the Year Award at AAIC 2024
Our CSO, Dr. Adolfo García, obtained the Publication of the Year Award from the Alzheimer’s Association in the Diversity and Disparities category. Congratulations to Adolfo and colleagues!
TELL to collaborate with Harvard Medical School
Our TELL team is excited to partner with Brain Modulation Lab and MGH Neurosurgery, at Harvard Medical School, to conduct groundbreaking research on intracranial signatures of speech. Learn more about Brain Modulation Lab here and about MGH Neurosurgery here.